Catalyst Wire Dossier Catalyst Wire Dossier

XL119

· Helsinn Healthcare SA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XL119, covering 2009-01-14 to 2009-01-14. Get the full timeline:

Most recent: Clinical Trial Update: XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors [Phase 3]

See pricing